Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk

Abstract

Biopsy Decipher predicted the risk of metastasis at 10 years post radical prostatectomy. While further validation is required on larger cohorts, preoperative knowledge of Decipher risk derived from biopsy could indicate the need for multimodality therapy and help set patient expectations of therapeutic burden.